Molecular Pathology and Cytology Branch (J.D.S.), Center for Devices and Radiological Health, Division of Molecular Genetics and Pathology, Office of In Vitro Diagnostics and Radiological Health, Food and Drug Administration, Silver Spring
Department of Pathology Obstetrics and Gynecology (R.V.), Johns Hopkins Medical Institutions, Baltimore, Maryland
Department of Pathology (J.K.), Washington Hospital Center, Washington, District of Columbia
Department of Pathology (A.Y.), MD Anderson Cancer Center, Austin, Texas
This work is unrelated to Dr. Seidman's employment at the FDA. The opinions and assertions herein are the private views of the authors and do not purport to reflect those of the FDA or any part of the US government. The authors declare no conflict of interest.
Address correspondence and reprint requests to Jeffrey D. Seidman, Molecular Pathology and Cytology Branch, Division of Molecular Genetics and Pathology, Office of In Vitro Diagnostics and Radiological Health, Center for Devices and Radiological Health, 10903 New Hampshire Ave, Silver Spring, MD 20993. E-mail: [email protected].
